New ad urges Congress to take action on drug prices
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, yesterday released a new ad urging Congress to keep its commitment to lower drug prices. Seventeen organizations, including the AHA, this month urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors. The legislation closes the Medicare Part D coverage gap or “doughnut hole” one year earlier and requires higher drug manufacturer discounts on brand name prescription drugs while enrollees are in the coverage gap.
Related News Articles
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…